← Eichor
Condition: Growth Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Growth

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Placental Progesterone Membrane Receptors in Fetal Growth Restriction
Phase N/A · 1 location(s) · Samsun University · NCT07701837Natural History of Craniofacial Anomalies and Developmental Growth Variants
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT02639312Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program
NA · 1 location(s) · National University Hospital, Singapore · NCT07247123Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative
Phase 1/Phase 2 · 1 location(s) · Peking University People's Hospital · NCT04836156A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in N
NA · 1 location(s) · Massachusetts General Hospital · NCT01873131Fetal Growth Restriction a Case Control Study
Phase N/A · 2 location(s) · National University of Malaysia · NCT07025031Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies
NA · 1 location(s) · Maxima Medical Center · NCT06859177Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Gl
Phase 1/Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06059690Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT06928818A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC
Phase 2 · 1 location(s) · Sichuan University · NCT06951464Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
Phase 1/Phase 2 · 12 location(s) · Artios Pharma Ltd · NCT05898399KETOgenic Diet Therapy in Patients With ACROmegaly
NA · 1 location(s) · Erasmus Medical Center · NCT06949891Maternal Characteristics Associated With Child Growth and Adiposity
Phase N/A · 1 location(s) · Instituto de Desarrollo e Investigaciones Pediátricas Prof. · NCT05798676Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT05985655Psychological Factors Influencing Cancer Post-traumatic Growth
NA · 1 location(s) · Centre Hospitalier de Valenciennes · NCT06278558Targeted Fortification of Donor Breast Milk in Preterm Infants
NA · 1 location(s) · Columbia University · NCT04294368Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
NA · 1 location(s) · Driscoll Children's Hospital · NCT07087782A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2-
Phase 3 · 1 location(s) · Genentech, Inc. · NCT07541079Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surge
Phase 2 · 4 location(s) · University of Chicago · NCT06348134Optimizing Early Nutrition Management of Extremely and/or Very Preterm Infants
NA · 1 location(s) · Children's Hospital of Fudan University · NCT07538999Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy
Phase 3 · 18 location(s) · Dompé Farmaceutici S.p.A · NCT07453888Open, Non-comparative Pilot Study to Evaluate the Safety and Efficacy of Intraovarian Plasma Rich in Growth Factors (PRG
NA · 1 location(s) · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT06975683A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers
Phase N/A · 1 location(s) · Société des Produits Nestlé (SPN) · NCT04916652Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Phase N/A · 1 location(s) · Cedars-Sinai Medical Center · NCT02910180Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients
Phase N/A · 1 location(s) · Antonio Bellasi · NCT06668831PIERS and BIS, sFIT:PIGF, Adrenomedullin
Phase N/A · 1 location(s) · Suez Canal University · NCT02578810A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
Phase 2 · 3 location(s) · Yale University · NCT02491099Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Phase N/A · 3 location(s) · University Hospital, Angers · NCT03812913Growth Hormone Resistance of Beta-cells A
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT06571487To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Alle
Phase 2 · 2 location(s) · Min-Tze LIONG · NCT07490587
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.